The primary goal of the UNC CFAR Clinical Core (Core C) is to facilitate and enhance clinical and? translational HIV/AIDS research at UNC, Family Health International (FHI) and Research Triangle Institute? (RTI). Core C accomplishes this goal by serving CFAR members who are established in HIV clinical and? translational research and seeking out and assisting new investigators including experienced HIV basic? scientists new to translational research, experienced clinical investigators new to HIV/AIDS and especially? junior investigators establishing themselves in HIV research. Core C is composed of Dr. Joseph Eron? (Director), Ms. Prema Menezes (Associate Core Director), Dr. Sonia Napravnik, (Epidemiologist), Dr.? Christopher Pilcher (Core Investigator), Dr. Evelyn Quinlivan (Core Investigator), a part time study? coordinator, two full time research assistants, one full-time clinic screener, a part time research assistant,? and two part time programmers / computer specialists.? Specific services offered include: assistance with design, development and conduct of clinical and? translational studies including subject identification, recruitment and consent, project coordination, obtaining? clinical samples, database design and management; NIH grant submission, IRB, GCRC and FDA? investigational and orphan drug application support; access to the UNC CFAR HIV/AIDS Clinical Research? Database (UNC CFAR-DB) and linked specimen repository including over 1700 consented participants to? date; access to comprehensive data from the Clinical Socio-Demographic in-person survey including? detailed behavioral information; access to the UNC Acute HIV Infection Clinical Research Program expertise? and data; and access to HIV basic and clinical investigators on the three UNC CFAR campuses and from? outside institutions. Core C has used these services to support a large variety of studies including HIV? vaccine development (AI46023, AI50246), cellular immunology (AI20288, GM67143), the biology of HIV? transmission (DK49381), acute HIV infection (MH68686), V3 (envelope) evolution (AI44667), HIV resistance? (AI50845), HIV prevention (AI46749, MH69989), and antiretroviral and other HIV clinical trials (AI25868).? Core C has provided leadership in HIV/AIDS Research communication by establishing a CFAR-wide? local area network (LAN), the comprehensive UNC CFAR-DB and linked specimen repository, a monthly? collaborative research meeting and a yearly AIDS symposium. Core C enhances training of medical and? graduate students, post doctoral fellows and junior investigators as evidenced by support of student research? projects, CFAR developmental awards and K-23 awards. Core C also helped establish productive? collaborations with outside institutions and industry. Outreach efforts to international collaborators, and to? HIV investigators, clinicians and HIV-infected individuals in the community are ongoing.?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI050410-09
Application #
7119716
Study Section
Special Emphasis Panel (ZAI1-BDP-A (J1))
Project Start
2006-06-01
Project End
2011-07-31
Budget Start
2006-06-01
Budget End
2007-07-31
Support Year
9
Fiscal Year
2006
Total Cost
$307,685
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Chi, Benjamin H; Mutale, Wilbroad; Winston, Jennifer et al. (2018) Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia. Pediatr Infect Dis J 37:1137-1141
Phillips, Bonnie; Van Rompay, Koen K A; Rodriguez-Nieves, Jennifer et al. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. J Virol 92:
Dubé, Karine; Evans, David; Dee, Lynda et al. (2018) ""We Need to Deploy Them Very Thoughtfully and Carefully"": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry. AIDS Res Hum Retroviruses 34:67-79
Hampel, Daniela; Shahab-Ferdows, Setareh; Gertz, Erik et al. (2018) The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers. Matern Child Nutr 14:e12503
Levintow, Sara N; Okeke, Nwora Lance; Hué, Stephane et al. (2018) Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort. Open Forum Infect Dis 5:ofy178
Mitchell, John T; LeGrand, Sara; Hightow-Weidman, Lisa B et al. (2018) Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial. JMIR Mhealth Uhealth 6:e10456
Miller, William C; Hoffman, Irving F; Hanscom, Brett S et al. (2018) A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study. Lancet 392:747-759
Kane, Jeremy C; Hall, Brian J; Bolton, Paul et al. (2018) The Association of Domestic Violence and Social Resources With Functioning in an Adult Trauma-Affected Sample Living in Kurdistan, Northern Iraq. J Interpers Violence 33:3772-3791
Rosen, David L; Grodensky, Catherine A; Miller, Anna R et al. (2018) Implementing a Prison Medicaid Enrollment Program for Inmates with a Community Inpatient Hospitalization. J Urban Health 95:149-158
Wang, Cheng; Tucker, Joseph D; Liu, Chuncheng et al. (2018) Condom use social norms and self-efficacy with different kinds of male partners among Chinese men who have sex with men: results from an online survey. BMC Public Health 18:1175

Showing the most recent 10 out of 1688 publications